Asra Ahmed

1.0k total citations
16 papers, 707 citations indexed

About

Asra Ahmed is a scholar working on Hematology, Physiology and Molecular Biology. According to data from OpenAlex, Asra Ahmed has authored 16 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Asra Ahmed's work include Histiocytic Disorders and Treatments (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Protein Degradation and Inhibitors (3 papers). Asra Ahmed is often cited by papers focused on Histiocytic Disorders and Treatments (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Protein Degradation and Inhibitors (3 papers). Asra Ahmed collaborates with scholars based in United States, Canada and Poland. Asra Ahmed's co-authors include Mark Kaminski, Ammar Al-Zoubi, Andrzej Jakubowiak, Moshe Talpaz, Erica Campagnaro, Kathryn McDonnell, M. Mietzel, Keith Stockerl‐Goldstein, Tara Anderson and Kent A. Griffith and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Cellular Physiology.

In The Last Decade

Asra Ahmed

13 papers receiving 700 citations

Peers

Countries citing papers authored by Asra Ahmed

Since Specialization

Citations

This map shows the geographic impact of Asra Ahmed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asra Ahmed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asra Ahmed more than expected).

Fields of papers citing papers by Asra Ahmed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asra Ahmed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asra Ahmed. The network helps show where Asra Ahmed may publish in the future.

Co-authorship network of co-authors of Asra Ahmed

This figure shows the co-authorship network connecting the top 25 collaborators of Asra Ahmed. A scholar is included among the top collaborators of Asra Ahmed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asra Ahmed. Asra Ahmed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	High Prevalence of Concomitant Autoimmunity in Patients with Rosai-Dorfman Disease 2024 ·Blood ·(unknown), Gordon Ruan, (unknown), (unknown), Xi Yang, Diana Morlote, Aishwarya Ravindran, Lauren Shea, Matthew J. Koster, Jithma P. Abeykoon, (unknown), Xinxin Cao, Asra Ahmed, Ronald S. Go, Gaurav Goyal	0
2	Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease 2023 ·Annals of Hematology ·(unknown), (unknown), Qing Li, Asra Ahmed	1
3	Skin-limited Langerhans cell histiocytosis in an adult presenting as isolated, eroded, “kissing” intergluteal plaques 2023 ·JAAD Case Reports ·(unknown), (unknown), Asra Ahmed, Emily H. Smith, Frank Wang	0
4	Relative Monocytosis Is Predictive of Disease Progression and Confirmatory of Response Assessment in Langerhans Cell Histiocytosis 2023 ·Blood ·(unknown), (unknown), Qing Li, (unknown), Asra Ahmed	0
5	Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial 2019 ·The Lancet Haematology ·Asra Ahmed, Samuel A. Merrill, (unknown), Paula Bockenstedt, Erica Campagnaro, Sumana Devata, Scott D. Gitlin, Mark Kaminski, (unknown), Tycel Phillips, Suman L. Sood, Moshe Talpaz, Albert Quiery, Philip S. Boonstra, Ryan A. Wilcox	191
6	Rosai–Dorfman disease simulating metastatic breast carcinoma 2019 ·JAAD Case Reports ·(unknown), (unknown), May P. Chan, Asra Ahmed, (unknown)	3
7	Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study 2018 ·Blood ·(unknown), Samuel A. Merrill, Paula Bockenstedt, Erica Campagnaro, Sumana Devata, Scott D. Gitlin, Mark Kaminski, (unknown), Tycel Phillips, Suman L. Sood, Moshe Talpaz, Albert Quiery, Philip S. Boonstra, Asra Ahmed, Ryan A. Wilcox	1
8	Pushing Critical Thinking Skills With Multiple-Choice Questions: Does Bloom’s Taxonomy Work? 2017 ·Academic Medicine ·Nikki L. Bibler Zaidi, (unknown), Seetha U. Monrad, Joshua Kurtz, Andrew W. Tai, Asra Ahmed, Larry D. Gruppen, Sally A. Santen	55
9	Finding the elusive and causative autoantibody: An atypical case of autoimmune hemolytic anemia 2015 ·Clinical Case Reports ·(unknown), Asra Ahmed, Laura Cooling	1
10	Caspase 3 activity in isolated fetal rat lung fibroblasts and rat periodontal ligament fibroblasts: cigarette smoke induced alterations 2013 ·Tobacco Induced Diseases ·Asra Ahmed, James A. Thliveris, (unknown), Michael G. Sowa, James S.C. Gilchrist, J. E. Scott	10
11	Cigarette Smoke Induces Apoptosis by Activation of Caspase-3 in Isolated Fetal Rat Lung Type II Alveolar Ep-ithelial Cells <i>in Vitro</i> 2013 ·Asra Ahmed, James A. Thliveris, (unknown), (unknown), James S.C. Gilchrist, (unknown)	1
12	Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up. 2013 ·Journal of Clinical Oncology ·Andrzej Jakubowiak, Dominik Dytfeld, Kent A. Griffith, Jagoda Jasielec, Kathryn McDonnell, Daniel Lebovic, David H. Vesole, Sundar Jagannath, (unknown), Tara Anderson, Kristen Detweiler‐Short, Keith Stockerl‐Goldstein, Asra Ahmed, (unknown), Diane E. Durecki, M. Mietzel, Daniel R. Couriel, Ravi Vij, Mark Kaminski	13
13	A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma 2012 ·Blood ·Andrzej Jakubowiak, Dominik Dytfeld, Kent A. Griffith, Daniel Lebovic, David H. Vesole, Sundar Jagannath, Ammar Al-Zoubi, Tara Anderson, (unknown), Kristen Detweiler‐Short, Keith Stockerl‐Goldstein, Asra Ahmed, (unknown), Diane E. Durecki, Kathryn McDonnell, M. Mietzel, Daniel R. Couriel, Mark Kaminski, Ravi Vij	311
14	Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma 2009 ·Journal of Clinical Oncology ·Andrzej Jakubowiak, Tara Kendall, Ammar Al-Zoubi, Yasser Khaled, Shin Mineishi, Asra Ahmed, Erica Campagnaro, (unknown), Thomas Braun, Moshe Talpaz, Mark Kaminski	57
15	High Rate of Complete and near Complete Responses (CR/nCR) after Initial Therapy with Bortezomib (Velcade®), Doxil®, and Dexamethasone (VDD) Is Further Increased after Autologous Stem Cell Transplantation (ASCT). 2006 ·Blood ·Andrzej Jakubowiak, Ammar Al-Zoubi, Tara Kendall, (unknown), Asra Ahmed, Yasser Khaled, Shin Mineishi, Mark Kaminski	10
16	Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor 1989 ·Journal of Cellular Physiology ·(unknown), (unknown), Greg Conn, Asra Ahmed, (unknown), (unknown), Victor B. Hatcher	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact